Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by drippingsnoton Sep 09, 2020 2:41pm
76 Views
Post# 31527694

RE:RE:RE:RE:my turn ...

RE:RE:RE:RE:my turn ...Good question CyKill.

If I could have my way ?

Need the company to play up the efficiencies it finds.
Need the company to play up the release of CRESEMBA in Brazil.
Looking for at least one CANADA/LATAM drug to be negotiated in September.
Better yet ... would be a partnership with a larger pharma and a starting drug or a portfolio to come our way.

Would be nice to strike a deal for Moksha8 in Sept/Oct but that is highly unlikely unless it was already in the works.

Something like that ... to say ... "Here we go ....!"

: )
<< Previous
Bullboard Posts
Next >>